Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › SC › GREENVILLE › ASSURE LABORATORY INC

ASSURE LABORATORY INC

NPI: 1386110153 · GREENVILLE, SC 29607 · Clinical Medical Laboratory · NPI assigned 10/19/2018

$403K
Total Medicaid Paid
47,338
Total Claims
27,865
Beneficiaries
90
Codes Billed
2020-11
First Month
2023-09
Last Month

Provider Details

Authorized OfficialHODGES, JEAN (CEO)
NPI Enumeration Date10/19/2018

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 245 $17K
2021 1,879 $121K
2022 27,522 $129K
2023 17,692 $136K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 3,788 1,099 $306K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,648 489 $34K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 373 121 $13K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,228 1,340 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 499 343 $3K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 222 127 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 793 245 $3K
84443 Thyroid stimulating hormone (TSH) 2,500 1,474 $2K
87150 410 114 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 257 190 $2K
87631 115 66 $2K
80061 Lipid panel 2,892 1,749 $2K
80053 Comprehensive metabolic panel 3,521 2,062 $2K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3,558 2,053 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,971 664 $2K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 114 90 $1K
82607 1,439 911 $1K
83036 Hemoglobin; glycosylated (A1C) 1,722 1,168 $1K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 75 54 $1K
84481 651 480 $984.73
82728 980 663 $697.31
82746 783 546 $678.65
87581 253 171 $603.85
87486 253 171 $602.09
84439 1,149 799 $578.40
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 210 152 $506.70
86803 519 387 $501.89
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 351 285 $481.12
84681 368 302 $455.22
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 210 152 $454.37
84403 328 238 $430.75
86376 378 295 $364.23
83540 981 682 $360.56
86800 310 258 $360.39
87517 53 34 $334.17
83550 701 474 $319.55
84153 295 218 $319.14
36415 Collection of venous blood by venipuncture 2,724 1,537 $316.35
86141 285 232 $305.55
86704 379 293 $303.76
83735 677 486 $293.48
87086 Culture, bacterial; quantitative colony count, urine 627 355 $272.38
86709 423 315 $269.56
83525 372 307 $250.11
82670 76 52 $207.34
87340 318 243 $195.45
87500 160 114 $191.58
87641 152 111 $175.12
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 139 106 $166.71
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 88 64 $131.47
85060 106 58 $129.47
84436 427 313 $127.95
82043 412 315 $124.49
84270 95 79 $122.69
80050 General health panel 210 208 $122.21
87522 Neg quan hep c or qual rna 35 27 $107.10
83002 64 52 $106.56
86706 79 68 $104.27
86592 296 226 $101.40
87481 245 133 $96.09
84154 79 68 $75.05
87653 179 131 $74.37
86705 68 47 $71.84
86431 201 155 $68.71
83001 43 35 $65.08
87640 165 118 $60.33
86696 41 30 $58.95
86695 78 58 $56.64
87070 152 81 $54.27
84702 33 28 $39.15
86038 44 32 $33.13
82465 68 44 $23.04
85652 92 50 $22.82
84479 60 46 $19.51
84144 16 12 $18.78
82248 67 50 $13.56
82977 16 12 $12.96
82540 20 14 $12.63
84466 14 14 $11.50
83721 43 27 $8.27
85610 17 14 $7.76
84478 43 27 $5.17
82040 22 19 $1.71
84450 38 29 $0.00
86003 70 48 $0.00
84100 37 26 $0.00
84460 50 41 $0.00
84550 42 31 $0.00
85049 21 17 $0.00
84480 232 201 $0.00